Awards & Incentives
You may be eligible for these awards when you submit an abstract

Awards & Incentives

Please note: 2021 Travel Award winners can redeem their awards for the 2022 Annual Meeting. Fill out the expense voucher form below.

Travel Award Winners: Download a Voucher

Outstanding Achivement Award

The ASGCT Outstanding Achievement Award recognizes an ASGCT Member who has achieved a pioneering research success, specific high-impact accomplishment, or lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor and the recipient is celebrated at the ASGCT Annual Meeting. The recipient presents a plenary lecture highlighting their scientific accomplishments that led to the award.

Outstanding New Investigator Award

Several Outstanding New Investigators are recognized each year based on their contributions to the field of gene and cell therapy. Investigators from academia, research foundations, government, and industry are all eligible to be nominated for awards. Recipients of the Outstanding New Investigator Awards are celebrated at the ASGCT Annual Meeting every year. Each awardee will present a plenary lecture highlighting their scientific accomplishments that led to the Award.

Founders Award

Established in 2022, the ASGCT Founders Award recognizes a pioneering contributor to the gene and cell therapy field. It is among the Society’s highest honors and the recipient is celebrated at the ASGCT Annual Meeting. The recipient presents a keynote lecture highlighting their scientific accomplishments that led to the award.

Sonia Skarlatos Public Service Award

Named for its inaugural co-recipient and tireless gene therapy advocate, the ASGCT’s Sonia Skarlatos Public Service Award recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education, or non-governmental charitable organizations. Both ASGCT Members and non-Members are eligible to receive the award.

Jerry Mendell Award for Translational Science

Named for the first person to study viral mediated gene therapy for muscular dystrophy in humans, and the principal investigator in the study that led to the FDA approval of Zolgensma to treat SMA, the Jerry Mendell Award for Translational Science recognizes the extensive work required to bring gene and cell therapies to clinical trial. Supported by a generous grant from Dr. Suku and Ann Nagendran.

Best of Molecular Therapy Award

The Best of Molecular Therapy Award, supported by Phil and Nancy Reilly, highlights the contribution of a lead author under the age of 40 to the Molecular Therapy family of journals.

Excellence in Research Awards

The top ten to fifteen abstracts submitted by students and fellows will receive an Excellence in Research Award. Recipients will be announced at the end of the George Stamatoyannopoulos plenary lecture and will receive a monetary award of $500 and a special plaque.

Supported by:

  

Meritorious Abstract Travel Awards

ASGCT supports the travel of approximately 150 Associate Members each year through the Meritorious Abstract Travel Award program. Awards are given out based on high abstract scores and recipients will receive a certificate and a travel reimbursement stipend of up to $500 for domestic awardees and $600 for international awardees.

Supported by:

Outstanding Poster Presentation Awards

The top poster presentations from each of the poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards. Awardees are honored through notification to all meeting attendees and receive a special certificate for their contributions.

Underrepresented Population Travel Awards

ASGCT will offer a limited number of Underrepresented Population Travel Awards ($500 value) to Associate Members submitting an abstract to the meeting. Eligible candidates must be a U.S. resident and self-identify as Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian, Indigenous, or other Pacific Islander.

Supported by:

 

Funding for these awards was made possible (in part) by 1R13TR004216-01 from the National Center for Advancing Translational Sciences (NCATS). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.